Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AML
Clinical trial NCT06434662 · UNKNOWN
Trial details
- NCT number
- NCT06434662
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-29
- Primary completion
- 2025-06-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.